Cochrane Abstracts
Magnetic resonance perfusion for differentiating low‐grade from high‐grade gliomas at first presentation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Magnetic Resonance Perfusion for Differentiating Low‐grade From High‐grade Gliomas at First Presentation." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433350/all/Magnetic_resonance_perfusion_for_differentiating_low‐grade_from_high‐grade_gliomas_at_first_presentation.
Magnetic resonance perfusion for differentiating low‐grade from high‐grade gliomas at first presentation. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433350/all/Magnetic_resonance_perfusion_for_differentiating_low‐grade_from_high‐grade_gliomas_at_first_presentation. Accessed January 19, 2025.
Magnetic resonance perfusion for differentiating low‐grade from high‐grade gliomas at first presentation. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433350/all/Magnetic_resonance_perfusion_for_differentiating_low‐grade_from_high‐grade_gliomas_at_first_presentation
Magnetic Resonance Perfusion for Differentiating Low‐grade From High‐grade Gliomas at First Presentation [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433350/all/Magnetic_resonance_perfusion_for_differentiating_low‐grade_from_high‐grade_gliomas_at_first_presentation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Magnetic resonance perfusion for differentiating low‐grade from high‐grade gliomas at first presentation
ID - 433350
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433350/all/Magnetic_resonance_perfusion_for_differentiating_low‐grade_from_high‐grade_gliomas_at_first_presentation
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
